Healthcare -
Biotechnology - NASDAQ - CH
$ 43.81
5.64 %
$ 2.76 B
Market Cap
-34.5
P/E
Price Target
Average
82.61%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
45.60%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
MoonLake Immunotherapeutics
Wall Street analysts predict an average 1-year price target for MLTX of $80 , with forecasts ranging from
a
low of
$62 to a high of $100 .
MLTX Lowest Price Target
Wall Street Target
62 USD
41.52%
MLTX Average Price Target
Wall Street Target
80 USD
82.61%
MLTX Highest Price Target
Wall Street Target
100 USD
128.26%
REVENUE FORECAST
Revenue Forecast Chart MLTX
EBIT FORECAST
EBIT Forecast Chart MLTX
NET INCOME FORECAST
Net Income Chart MLTX